Propionic Acid

Propionic Acid

SCHEMBL4159523

CCC(=O)O.O=c1[nH]c2ccc(C#Cc3ccccn3)cc2c2cc[nH]c12

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.43
NPC1 O15118 4/20 0.41
HCRTR1 O43613 3/20 0.41
RAB9A P51151 3/20 0.41
POLB P06746 2/20 0.39
PTPN7 P35236 1/20 0.39
DUSP3 P51452 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
ERN1 O75460 1/20 0.38
HAO1 Q9UJM8 2/20 0.38
CASP3 P42574 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
IP6K1 Q92551 1/20 0.37
IP6K3 Q96PC2 1/20 0.37
IP6K2 Q9UHH9 1/20 0.37
GRM5 P41594 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
GABRA1 P14867 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4160296 0.88 GRM5 (0.44) FFAR1NPC1RAB9AIP6K1IP6K3
Propionic Acid SCHEMBL4160262 0.84 GABRA1 (0.48) IP6K1IP6K3IP6K2GRM5GABRA1
Propionic Acid SCHEMBL4165408 0.79 GABRA1 (0.39) POLBGABRA1GABRG2GABRB3GABRA5
Propionic Acid SCHEMBL4162291 0.79 PDE2A (0.39) HAO1GABRA1GABRG2GABRB3GABRA5
Propionic Acid SCHEMBL4155568 0.78 PIM1 (0.41) GABRA1GABRG2GABRB3GABRA5GABRA3
Propionic Acid SCHEMBL4153840 0.77 PIM1 (0.44) NPC1GABRA1GABRG2GABRB3GABRA5
SCHEMBL4159518 0.77 FFAR1 (0.50) FFAR1NPC1HCRTR1RAB9APOLB
SCHEMBL3254573 0.77 HAO1 (0.41) FFAR1NPC1HCRTR1RAB9APOLB
Propionic Acid SCHEMBL4159927 0.76 ALDH1A1 (0.40) HCRTR1RAB9APOLB
Propionic Acid SCHEMBL4157930 0.76 RXFP1 (0.38) NPC1RAB9ARXFP1GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 FFAR1 3984/4885NPC1 3366/4885HCRTR1 4098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.